Ratings by KeyBanc (Scott Schoenhaus)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 7/13/2026 | Omnicell | OMCL | Maintain | Overweight (N/A) |
|
Details | ||
| 7/13/2026 | Waystar Holding | WAY | Maintain | Overweight (N/A) |
|
Details | ||
| 7/13/2026 | Progyny | PGNY | Maintain | Overweight (N/A) |
|
Details | ||
| 7/13/2026 | Hinge Health Inc | HNGE | Maintain | Overweight (N/A) |
|
Details | ||
| 6/12/2026 | Hinge Health Inc | HNGE | Maintain | Overweight (N/A) |
|
Details | ||
| 6/2/2026 | Oddity Tech Ltd | ODD | Downgrade | Sector Weight (Overweight) |
13.98 (17.08) |
22.17% | Details | |
| 5/26/2026 | HealthEquity, Inc | HQY | Maintain | Overweight (N/A) |
|
Details | ||
| 5/14/2026 | Doximity Inc | DOCS | Downgrade | Sector Weight (Overweight) |
26.45 (21.77) |
-17.69% | Details | |
| 4/29/2026 | Omnicell | OMCL | Maintain | Overweight (N/A) |
|
Details | ||
| 4/13/2026 | Schrodinger | SDGR | Maintain | Overweight (N/A) |
|
Details | ||
| 4/13/2026 | Phreesia Inc. | PHR | Maintain | Overweight (N/A) |
|
Details | ||
| 4/13/2026 | Doximity Inc | DOCS | Maintain | Overweight (N/A) |
|
Details | ||
| 4/13/2026 | Certara Inc. | CERT | Maintain | Overweight (N/A) |
|
Details | ||
| 3/31/2026 | Phreesia Inc. | PHR | Maintain | Overweight (N/A) |
|
Details | ||
| 3/2/2026 | Progyny | PGNY | Maintain | Overweight (N/A) |
|
Details | ||
| 2/26/2026 | Oddity Tech Ltd | ODD | Maintain | Overweight (N/A) |
|
Details | ||
| 2/20/2026 | Oddity Tech Ltd | ODD | Maintain | Overweight (N/A) |
|
Details | ||
| 2/19/2026 | Alight Solutions | ALIT | Downgrade | Sector Weight (Overweight) |
1.31 (19.62) |
1397.71% | Details | |
| 1/8/2026 | Schrodinger | SDGR | Maintain | Overweight (N/A) |
|
Details | ||
| 1/8/2026 | Progyny | PGNY | Maintain | Overweight (N/A) |
|
Details | ||
| 1/8/2026 | Oddity Tech Ltd | ODD | Maintain | Overweight (N/A) |
|
Details | ||
| 1/8/2026 | Hinge Health Inc | HNGE | Maintain | Overweight (N/A) |
|
Details | ||
| 1/8/2026 | HealthEquity, Inc | HQY | Maintain | Overweight (N/A) |
|
Details | ||
| 1/8/2026 | Doximity Inc | DOCS | Maintain | Overweight (N/A) |
|
Details | ||
| 1/8/2026 | Certara Inc. | CERT | Maintain | Overweight (N/A) |
|
Details | ||
| 1/8/2026 | Alight Solutions | ALIT | Maintain | Overweight (N/A) |
|
Details | ||
| 1/8/2026 | Omnicell | OMCL | Upgrade | Overweight (Sector Weight) |
47.07 (44.92) |
-4.57% | Details | |
| 12/12/2025 | Veeva Systems | VEEV | Downgrade | Sector Weight (Overweight) |
229.16 (190.12) |
-17.04% | Details | |
| 12/3/2025 | Schrodinger | SDGR | Maintain | Overweight (N/A) |
|
Details | ||
| 11/12/2025 | Progyny | PGNY | Upgrade | Overweight (Sector Weight) |
23.62 (30.65) |
29.76% | Details | |
| 10/29/2025 | Simulations Plus | SLP | Maintain | Sector Weight (N/A) |
|
Details | ||
| 10/8/2025 | Schrodinger | SDGR | Maintain | Overweight (N/A) |
|
Details | ||
| 10/8/2025 | Phreesia Inc. | PHR | Maintain | Overweight (N/A) |
|
Details | ||
| 10/8/2025 | Oddity Tech Ltd | ODD | Maintain | Overweight (N/A) |
|
Details | ||
| 10/8/2025 | HealthEquity, Inc | HQY | Maintain | Overweight (N/A) |
|
Details | ||
| 10/8/2025 | Health Catalyst Inc. | HCAT | Maintain | Overweight (N/A) |
|
Details | ||
| 10/8/2025 | Doximity Inc | DOCS | Maintain | Overweight (N/A) |
|
Details | ||
| 10/8/2025 | Certara Inc. | CERT | Maintain | Overweight (N/A) |
|
Details | ||
| 8/22/2025 | Phreesia Inc. | PHR | Maintain | Overweight (N/A) |
|
Details | ||
| 8/19/2025 | Omnicell | OMCL | Maintain | Sector Weight (N/A) |
|
Details | ||
| 7/15/2025 | Simulations Plus | SLP | Downgrade | Sector Weight (Overweight) |
16.96 (18.24) |
7.55% | Details | |
| 6/16/2025 | Hinge Health Inc | HNGE | New Coverage | Overweight (N/A) |
0.00 (88.80) |
0% | Details | |
| 6/4/2025 | HealthEquity, Inc | HQY | Maintain | Overweight (N/A) |
|
Details | ||
| 5/14/2025 | GoodRx Holdings Inc. | GDRX | Maintain | Overweight (N/A) |
|
Details | ||
| 5/8/2025 | GoodRx Holdings Inc. | GDRX | Maintain | Overweight (N/A) |
|
Details | ||
| 4/16/2025 | Veeva Systems | VEEV | Maintain | Overweight (N/A) |
|
Details | ||
| 4/16/2025 | Simulations Plus | SLP | Maintain | Overweight (N/A) |
|
Details | ||
| 4/16/2025 | Schrodinger | SDGR | Maintain | Overweight (N/A) |
|
Details | ||
| 4/16/2025 | Phreesia Inc. | PHR | Maintain | Overweight (N/A) |
|
Details | ||
| 4/16/2025 | Oddity Tech Ltd | ODD | Maintain | Overweight (N/A) |
|
Details | ||
| 4/16/2025 | HealthEquity, Inc | HQY | Maintain | Overweight (N/A) |
|
Details | ||
| 4/16/2025 | Health Catalyst Inc. | HCAT | Maintain | Overweight (N/A) |
|
Details | ||
| 4/16/2025 | Doximity Inc | DOCS | Maintain | Overweight (N/A) |
|
Details | ||
| 4/16/2025 | Certara Inc. | CERT | Maintain | Overweight (N/A) |
|
Details | ||
| 4/16/2025 | Absci Corp. | ABSI | Maintain | Overweight (N/A) |
|
Details | ||
| 4/16/2025 | AbCellera Biologics | ABCL | Maintain | Overweight (N/A) |
|
Details | ||
| 3/24/2025 | Absci Corp. | ABSI | Maintain | Overweight (N/A) |
|
Details | ||
| 3/24/2025 | HealthEquity, Inc | HQY | Maintain | Overweight (N/A) |
|
Details | ||
| 3/14/2025 | Phreesia Inc. | PHR | Maintain | Overweight (N/A) |
|
Details | ||
| 2/28/2025 | Certara Inc. | CERT | Maintain | Overweight (N/A) |
|
Details | ||
| 2/28/2025 | Progyny | PGNY | Maintain | Sector Weight (N/A) |
|
Details | ||
| 2/19/2025 | Progyny | PGNY | Maintain | Sector Weight (N/A) |
|
Details | ||
| 2/7/2025 | Doximity Inc | DOCS | Maintain | Overweight (N/A) |
|
Details | ||
| 1/24/2025 | Schrodinger | SDGR | Maintain | Overweight (N/A) |
|
Details | ||
| 1/24/2025 | Simulations Plus | SLP | Maintain | Overweight (N/A) |
|
Details | ||
| 1/8/2025 | Veeva Systems | VEEV | Maintain | Overweight (N/A) |
|
Details | ||
| 1/8/2025 | Simulations Plus | SLP | Maintain | Overweight (N/A) |
|
Details | ||
| 1/8/2025 | Recursion Pharmaceuticals | RXRX | Maintain | Overweight (N/A) |
|
Details | ||
| 1/8/2025 | Phreesia Inc. | PHR | Maintain | Overweight (N/A) |
|
Details | ||
| 1/8/2025 | Oddity Tech Ltd | ODD | Maintain | Overweight (N/A) |
|
Details | ||
| 1/8/2025 | LifeMD Inc | LFMD | Maintain | Overweight (N/A) |
|
Details | ||
| 1/8/2025 | GoodRx Holdings Inc. | GDRX | Maintain | Overweight (N/A) |
|
Details | ||
| 1/8/2025 | Doximity Inc | DOCS | Maintain | Overweight (N/A) |
|
Details | ||
| 1/8/2025 | Absci Corp. | ABSI | Maintain | Overweight (N/A) |
|
Details | ||
| 1/8/2025 | AbCellera Biologics | ABCL | Maintain | Overweight (N/A) |
|
Details | ||
| 1/7/2025 | Health Catalyst Inc. | HCAT | Upgrade | Overweight (Sector Weight) |
7.40 (2.29) |
-69.05% | Details | |
| 11/20/2024 | Recursion Pharmaceuticals | RXRX | Maintain | Overweight (N/A) |
|
Details | ||
| 11/13/2024 | Alight Solutions | ALIT | Maintain | Overweight (N/A) |
|
Details | ||
| 11/8/2024 | Doximity Inc | DOCS | Upgrade | Overweight (Sector Weight) |
42.35 (26.45) |
-37.54% | Details | |
| 10/2/2024 | Recursion Pharmaceuticals | RXRX | Maintain | Overweight (N/A) |
|
Details | ||
| 9/30/2024 | Progyny | PGNY | Maintain | Sector Weight (N/A) |
|
Details | ||
| 9/18/2024 | HealthEquity, Inc | HQY | Maintain | Overweight (N/A) |
|
Details | ||
| 9/11/2024 | Omnicell | OMCL | Maintain | Sector Weight (N/A) |
|
Details | ||
| 9/4/2024 | HealthEquity, Inc | HQY | Maintain | Overweight (N/A) |
|
Details | ||
| 9/3/2024 | Recursion Pharmaceuticals | RXRX | Maintain | Overweight (N/A) |
|
Details | ||
| 8/29/2024 | Veeva Systems | VEEV | Maintain | Overweight (N/A) |
|
Details | ||
| 8/23/2024 | AbCellera Biologics | ABCL | Maintain | Overweight (N/A) |
|
Details | ||
| 8/13/2024 | Oddity Tech Ltd | ODD | Maintain | Overweight (N/A) |
|
Details | ||
| 8/13/2024 | Progyny | PGNY | Maintain | Sector Weight (N/A) |
|
Details | ||
| 7/29/2024 | Simulations Plus | SLP | New Coverage | Overweight (N/A) |
39.49 (16.96) |
-57.05% | Details | |
| 7/11/2024 | Schrodinger | SDGR | Maintain | Overweight (N/A) |
|
Details | ||
| 7/11/2024 | Recursion Pharmaceuticals | RXRX | Maintain | Overweight (N/A) |
|
Details | ||
| 7/11/2024 | Phreesia Inc. | PHR | Maintain | Overweight (Overweight) |
|
Details | ||
| 7/11/2024 | LifeMD Inc | LFMD | Maintain | Overweight (N/A) |
|
Details | ||
| 7/11/2024 | Certara Inc. | CERT | Maintain | Overweight (N/A) |
|
Details | ||
| 7/11/2024 | Alight Solutions | ALIT | Maintain | Overweight (N/A) |
|
Details | ||
| 7/11/2024 | Absci Corp. | ABSI | Maintain | Overweight (N/A) |
|
Details | ||
| 7/11/2024 | AbCellera Biologics | ABCL | Maintain | Overweight (N/A) |
|
Details | ||
| 6/26/2024 | Recursion Pharmaceuticals | RXRX | Maintain | Overweight (N/A) |
|
Details | ||
| 6/5/2024 | LifeMD Inc | LFMD | New Coverage | Overweight (N/A) |
7.53 (4.64) |
-38.38% | Details | |
| 6/4/2024 | HealthEquity, Inc | HQY | Maintain | Overweight (N/A) |
|
Details | ||
| 5/24/2024 | Phreesia Inc. | PHR | Maintain | Overweight (N/A) |
|
Details | ||
| 5/22/2024 | Oddity Tech Ltd | ODD | Maintain | Overweight (N/A) |
|
Details | ||
| 5/16/2024 | GoodRx Holdings Inc. | GDRX | Maintain | Overweight (N/A) |
|
Details | ||
| 5/16/2024 | AbCellera Biologics | ABCL | Maintain | Overweight (N/A) |
|
Details | ||
| 5/10/2024 | Progyny | PGNY | Downgrade | Sector Weight (Overweight) |
32.16 (30.65) |
-4.7% | Details | |
| 5/9/2024 | Alight Solutions | ALIT | Maintain | Overweight (N/A) |
|
Details | ||
| 5/8/2024 | AbCellera Biologics | ABCL | Maintain | Overweight (N/A) |
|
Details | ||
| 4/10/2024 | R1 RCM Inc | RCM | Downgrade | Sector Weight (Overweight) |
12.77 (14.31) |
12.06% | Details | |
| 4/10/2024 | Health Catalyst Inc. | HCAT | Downgrade | Sector Weight (Overweight) |
6.60 (7.40) |
12.12% | Details | |
| 4/10/2024 | GoodRx Holdings Inc. | GDRX | Upgrade | Overweight (Sector Weight) |
6.84 (2.95) |
-56.87% | Details | |
| 4/10/2024 | Certara Inc. | CERT | Upgrade | Overweight (Sector Weight) |
18.94 (6.77) |
-64.26% | Details | |
| 3/22/2024 | HealthEquity, Inc | HQY | Maintain | Overweight (N/A) |
|
Details | ||
| 3/20/2024 | Alight Solutions | ALIT | Maintain | Overweight (N/A) |
|
Details | ||
| 3/13/2024 | Teladoc | TDOC | Maintain | Sector Weight (N/A) |
|
Details | ||
| 3/5/2024 | Veeva Systems | VEEV | Maintain | Overweight (N/A) |
|
Details | ||
| 3/4/2024 | Absci Corp. | ABSI | Maintain | Overweight (N/A) |
|
Details | ||
| 2/29/2024 | Schrodinger | SDGR | Maintain | Overweight (N/A) |
|
Details | ||
| 2/28/2024 | Progyny | PGNY | Maintain | Overweight (N/A) |
|
Details | ||
| 1/24/2024 | Veeva Systems | VEEV | Maintain | Overweight (N/A) |
|
Details | ||
| 1/5/2024 | R1 RCM Inc | RCM | Maintain | Overweight (N/A) |
|
Details | ||
| 1/5/2024 | Absci Corp. | ABSI | Maintain | Overweight (N/A) |
|
Details | ||
| 1/5/2024 | AbCellera Biologics | ABCL | Maintain | Overweight (N/A) |
|
Details | ||
| 12/5/2023 | Schrodinger | SDGR | New Coverage | Overweight (N/A) |
32.49 (16.49) |
-49.25% | Details | |
| 12/5/2023 | Certara Inc. | CERT | New Coverage | Sector Weight (N/A) |
14.64 (6.77) |
-53.76% | Details | |
| 12/5/2023 | Absci Corp. | ABSI | New Coverage | Overweight (N/A) |
1.74 (10.60) |
509.2% | Details | |
| 12/5/2023 | AbCellera Biologics | ABCL | New Coverage | Overweight (N/A) |
4.83 (6.80) |
40.79% | Details | |
| 11/8/2023 | Progyny | PGNY | Maintain | Overweight (N/A) |
|
Details | ||
| 10/11/2023 | Veeva Systems | VEEV | Maintain | Overweight (N/A) |
|
Details | ||
| 10/11/2023 | Omnicell | OMCL | Downgrade | Sector Weight (Overweight) |
43.80 (47.07) |
7.47% | Details | |
| 8/14/2023 | Oddity Tech Ltd | ODD | New Coverage | Overweight (N/A) |
46.35 (13.98) |
-69.84% | Details | |
| 8/4/2023 | Progyny | PGNY | Maintain | Overweight (N/A) |
|
Details | ||
| 7/13/2023 | Recursion Pharmaceuticals | RXRX | Maintain | Overweight (N/A) |
|
Details | ||
| 7/13/2023 | Omnicell | OMCL | Maintain | Overweight (N/A) |
|
Details | ||
| 6/2/2023 | Veeva Systems | VEEV | Maintain | Overweight (N/A) |
|
Details | ||
| 5/25/2023 | Veeva Systems | VEEV | Maintain | Overweight (N/A) |
|
Details | ||
| 5/25/2023 | Phreesia Inc. | PHR | Maintain | Overweight (N/A) |
|
Details | ||
| 5/3/2023 | Omnicell | OMCL | Maintain | Overweight (Overweight) |
|
Details | ||
| 4/20/2023 | Health Catalyst Inc. | HCAT | Upgrade | Overweight (Sector Weight) |
13.09 (2.29) |
-82.51% | Details | |
| 2/2/2023 | R1 RCM Inc | RCM | Maintain | Overweight (N/A) |
|
Details | ||
| 2/2/2023 | Phreesia Inc. | PHR | Maintain | Overweight (N/A) |
|
Details | ||
| 2/2/2023 | Omnicell | OMCL | Maintain | Overweight (N/A) |
|
Details | ||
| 12/19/2022 | Progyny | PGNY | Maintain | Overweight (N/A) |
|
Details | ||
| 12/5/2022 | Veeva Systems | VEEV | Maintain | Overweight (N/A) |
|
Details | ||
| 12/5/2022 | R1 RCM Inc | RCM | Maintain | Overweight (N/A) |
|
Details | ||
| 11/9/2022 | R1 RCM Inc | RCM | Maintain | Overweight (N/A) |
|
Details | ||
| 11/8/2022 | Benefitfocus | BNFT | Downgrade | Sector Weight (Overweight) |
10.39 (10.50) |
1.06% | Details | |
| 9/16/2022 | Veeva Systems | VEEV | New Coverage | Overweight (N/A) |
174.19 (229.16) |
31.56% | Details | |
| 9/16/2022 | Phreesia | PHR | New Coverage | Overweight (N/A) |
44.42 (10.72) |
-75.87% | Details | |
| 9/16/2022 | R1 RCM Inc | RCM | New Coverage | Overweight (N/A) |
21.20 (14.31) |
-32.5% | Details | |
| 9/16/2022 | Teladoc | TDOC | New Coverage | Sector Weight (N/A) |
31.67 (9.28) |
-70.7% | Details | |
| 9/16/2022 | Recursion Pharmaceuticals | RXRX | New Coverage | Overweight (N/A) |
13.47 (3.56) |
-73.57% | Details | |
| 9/16/2022 | Progyny | PGNY | New Coverage | Overweight (N/A) |
42.05 (30.65) |
-27.11% | Details | |
| 9/16/2022 | HealthEquity, Inc | HQY | New Coverage | Overweight (N/A) |
71.28 (94.40) |
32.44% | Details | |
| 9/16/2022 | GoodRx Holdings Inc. | GDRX | New Coverage | Sector Weight (N/A) |
6.42 (2.95) |
-54.05% | Details | |
| 9/16/2022 | Health Catalyst Inc. | HCAT | New Coverage | Sector Weight (N/A) |
11.17 (2.29) |
-79.5% | Details | |
| 9/16/2022 | Omnicell | OMCL | New Coverage | Overweight (N/A) |
97.37 (44.92) |
-53.87% | Details | |
| 9/16/2022 | Allscripts | MDRX | New Coverage | Sector Weight (N/A) |
16.51 (5.05) |
-69.41% | Details | |
| 9/16/2022 | HealthEquity, Inc | HQY | New Coverage | Overweight (N/A) |
71.28 (94.40) |
32.44% | Details | |
| 9/16/2022 | Doximity Inc | DOCS | New Coverage | Sector Weight (N/A) |
33.14 (42.35) |
27.79% | Details | |
| 9/16/2022 | Benefitfocus | BNFT | New Coverage | Overweight (N/A) |
6.71 (10.50) |
56.48% | Details | |
| 9/16/2022 | Alight Solutions | ALIT | New Coverage | Overweight (N/A) |
7.89 (19.62) |
148.67% | Details |
